Grandview Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,144
Closed -$232K 137
2025
Q1
$232K Buy
9,144
+113
+1% +$2.96K 0.09% 117
2024
Q4
$240K Buy
+9,031
New +$245K 0.09% 110
2024
Q2
Sell
-10,054
Closed -$279K 88
2024
Q1
$279K Buy
10,054
+145
+1% +$4.02K 0.13% 95
2023
Q4
$285K Sell
9,909
-46
-0.5% -$1.39K 0.15% 89
2023
Q3
$330K Buy
+9,955
New +$352K 0.19% 81
2023
Q2
Sell
-10,304
Closed -$420K 96
2023
Q1
$420K Buy
10,304
+81
+0.8% +$3.5K 0.25% 76
2022
Q4
$524K Sell
10,223
-1,003
-9% -$48.1K 0.33% 66
2022
Q3
$491K Sell
11,226
-916
-8% -$44.5K 0.31% 67
2022
Q2
$637K Sell
12,142
-3,055
-20% -$156K 0.36% 63
2022
Q1
$787K Buy
15,197
+1,826
+14% +$94.7K 0.33% 63
2021
Q4
$790K Buy
+13,371
New +$662K 0.32% 68
2021
Q3
Sell
-5,211
Closed -$204K 100
2021
Q2
$204K Buy
5,211
+728
+16% +$28.3K 0.11% 102
2021
Q1
$162K Buy
+4,483
New +$159K 0.09% 133
2020
Q1
Sell
-12,585
Closed -$467K 61
2019
Q4
$467K Sell
12,585
-649
-5% -$23.1K 0.44% 51
2019
Q3
$445K Sell
13,234
-98
-0.7% -$3.56K 0.4% 59
2019
Q2
$548K Sell
13,332
-974
-7% -$38.7K 0.51% 52
2019
Q1
$576K Buy
14,306
+122
+0.9% +$4.89K 0.53% 54
2018
Q4
$587K Buy
+14,184
New +$589K 0.62% 47

Other funds holding PFE

Grandview Asset Management's PFE Position: Q2 2025 in Review

Grandview Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 9,144 shares — an estimated $232K sold.

Grandview Asset Management first reported a position in PFE in Q4 2018 and held it in 18 quarters. The position peaked at $790K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Grandview Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Grandview Asset Management sold 9,144 Pfizer shares in Q2 2025, an estimated $232K.
  • Grandview Asset Management first reported a position in Pfizer in Q4 2018 and held it in 18 quarters.
  • Grandview Asset Management's Pfizer position peaked at $790K in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Grandview Asset Management's 13F filing for Q2 2025, filed 17 Jul 2025.